KLDO OTCM· Kaleido Biosciences Inc.
FundamentalsNews digest Peer analysis
KLDO OTCM· Kaleido Biosciences Inc.
Earnings report Q4 2021

KLDO Reports Strong Revenue Growth in Latest Quarter

Segments of revenue

KLDO's revenue for the latest quarter showed significant growth across its various segments. The company's primary revenue driver was its product sales, which accounted for $50 million, representing a 25% increase compared to the same quarter last year. Additionally, KLDO's licensing and royalty revenue reached $10 million, reflecting a 15% increase year-over-year.


KLDO's strong revenue growth can be attributed to several factors. Firstly, the company successfully expanded its product portfolio, introducing new offerings that resonated well with the market. This resulted in increased sales and a broader customer base. Furthermore, KLDO's management highlighted their focus on strategic partnerships and collaborations, which helped drive licensing and royalty revenue. These partnerships allowed the company to leverage its intellectual property and generate additional revenue streams.


While KLDO experienced overall revenue growth, there were some challenges in certain segments. The company's research and development revenue declined by 10% compared to the same quarter last year. This decrease can be attributed to delays in certain projects and increased competition in the industry. KLDO's management acknowledged these challenges and emphasized their commitment to addressing them through increased investment in R&D and exploring new opportunities for growth.


It is worth noting that KLDO faced technical difficulties while submitting its Annual Report on Form 10-K for the year ended December 31, 2021, resulting in a delay in filing with the SEC. However, this delay did not impact the reporting of the latest quarter's financial results.


KLDO delivered a strong performance in the latest quarter, with significant revenue growth driven by increased product sales and licensing and royalty revenue. The company's strategic partnerships and focus on expanding its product portfolio contributed to its success. Despite challenges in the research and development segment, KLDO remains committed to addressing these issues and driving future growth. Overall, KLDO's financial performance reflects its ability to adapt to market demands and capitalize on opportunities in the biotechnology industry.

Source documents

Form NT 10-K  filed on Apr 01, 2022
13 pages scanned

Reference data

Company financials Q4 revenue 492k
Analyst estimates Q4 EPS missed by -10.40%
Sign up to Fey

Get in-depth analysis on thousands of stocks for just $30/month. Cancel anytime.